| Product Name | Appearance | Source | Storage Conditions | Shipping Conditions | Inquiry |
|---|---|---|---|---|---|
| CD40 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| IFN beta Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| OR5F1 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| HMGB2 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| SATB1 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| SLC2A3 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20℃,2 years.(Avoid freeze/thaw cycles) | Shipped on dry ice | |
| VAMP1 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| CDK5 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| NUS1 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| MYLK Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| POPD1 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| PCYT2 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| CCL4L1/CCL4 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| ZCCHC4 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20℃,2 years.Avoid freeze/thaw cycles. | Shipped on dry ice | |
| TERT Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| ADGRG6 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| Acvrl1 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| CENPA Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| TLR7 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice | |
| BMP6 Antibody Blocking Peptide | Lyophilized powder | Synthetic | Store at -20°C. Avoid freeze / thaw cycles. | Shipped on dry ice |
Antibody blocking peptides are short, sequence-defined synthetic peptides that correspond precisely to the immunogen region used to generate a specific antibody. By competitively binding to the antibody’s paratope, these peptides serve as a gold-standard control for confirming antibody specificity across multiple immunodetection platforms, including Western blot (WB), immunohistochemistry (IHC), immunofluorescence (IF), and ELISA. When a blocking peptide effectively abolishes or significantly reduces the antibody signal, researchers gain strong evidence that the antibody is recognizing its intended epitope rather than nonspecific targets. Our blocking peptides are manufactured with ≥95% purity and undergo rigorous analytical verification to ensure consistency, bioactivity, and compatibility with assay conditions. Designed to support both routine laboratory validation and high-stakes research applications, these peptides provide a reliable and reproducible strategy for minimizing off-target binding, reducing background noise, and enhancing the interpretability of antibody-based experiments. Custom peptide synthesis services are also available for laboratories requiring tailored immunogen sequences, specialized modifications, or scaled production.
Blocking peptides function through competitive inhibition, a mechanism in which a synthetic peptide—identical or highly homologous to the antibody’s immunogen sequence—occupies the antibody’s antigen-binding site (paratope) before the antibody encounters its target protein. During pre-incubation, the blocking peptide binds to the antibody via sequence-specific interactions, effectively saturating the recognition sites that would otherwise engage with the corresponding epitope on the sample.
When the peptide-antibody mixture is applied to a Western blot membrane, tissue section, or cultured cells, the saturated antibody is no longer able to bind to the endogenous protein. As a result, a significant reduction or complete loss of signal is observed. This differential signal—with vs. without blocking peptide—serves as a powerful internal control to validate antibody specificity, rule out cross-reactivity, and distinguish true target detection from off-target or non-specific binding.
Because of this mechanism, blocking peptides are widely used in Western blot (WB), immunohistochemistry (IHC), immunofluorescence (IF), and ELISA, where antibody specificity is critical for accurate interpretation. The approach is especially valuable for antibodies targeting protein families with conserved domains, low-abundance targets, or membrane proteins prone to cross-reactivity. By providing a direct epitope-level competition, blocking peptides enable researchers to confirm true antigen recognition, enhance confidence in experimental results, and improve reproducibility across assays.We offer a full suite of customizable peptide solutions designed to support precise antibody validation, assay optimization, and advanced research workflows. Each service is executed with strict quality control and delivered with complete analytical documentation.
Blocking peptides play a critical role in confirming antibody specificity and improving the reliability of immunodetection assays. They are widely used across multiple research platforms where accurate target recognition is essential.
No. They are used as specificity controls to block antibody signal.
Blocking peptides are typically used at a 5–20× molar excess relative to the antibody.

Elevate the accuracy and reliability of your antibody-based experiments with our high-quality blocking peptides. Whether you need a catalog sequence or a fully customized design, our specialists are ready to support your research with precision synthesis, rigorous quality control, and rapid turnaround. Contact us today to request a quote, discuss your project needs, or start designing your custom blocking peptide solution.